Bellevue Group AG Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001674546

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q3 2023 · 154 positions · Total reported value $6.21B · Top-10 concentration 40.6% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 61.0% · 17 new · 64 cut · 24 exited

Active Share (vs S&P 500): 94.1% · vs QQQ: 96.5% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +12.4% · vs SPY -2.4% · Prev Value $4.20B — last quarter positions weighted by this quarter price moves · ranking

In its Q3 2023 13F filing, Bellevue Group AG disclosed 154 equity positions with a combined reported value of $6.21B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 40.6% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2023 were ARGX ($448.14M), IONS ($418.84M), VRTX ($348.69M). By sector, the heaviest allocations are Health Care 82.3%, Industrials 3.0%.

Versus the prior quarter, Bellevue Group AG opened 17 new positions, trimmed 64 and fully exited 24, a turnover rate of 61.0% of positions.

The largest new positions opened in Q3 2023 were ARGX ($448.14M), IONS ($418.84M), VRTX ($348.69M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2023)

  • ARGX ARGENX SE · $448.14M
  • IONS IONIS PHARMACEUTICALS INC · $418.84M
  • VRTX VERTEX PHARMACEUTICALS INC · $348.69M
  • NBIX NEUROCRINE BIOSCIENCES INC · $290.65M
  • ISRG INTUITIVE SURGICAL INC · $242.31M
  • ITCI INTRA-CELLULAR THERAPIES INC · $165.14M
  • ALNY ALNYLAM PHARMACEUTICALS INC · $158.39M
  • MRNA MODERNA INC · $154.45M

Fully Exited (vs previous quarter)

No tracked position was fully exited this quarter.

Insider Transactions (Form 4)

Latest Bellevue Group AG buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Bellevue Group AG files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 148 positions worth $4.75B in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Portfolio Structure

  • 148 positions · $4.75B reported value (Q2 2026)
  • Top 10 holdings = 42.9% of reported value
  • Largest position: AMGN (AMGEN INC) at 6.5%
  • Average position size: $32.11M

Sector Tilt

  • Health Care 92.6%
  • Industrials 1.7%
  • Information Technology 0.4%
  • (classified holdings cover 95% of value)

Quarterly Activity

  • Q2 2026: 17 new, 39 added, 64 reduced, 24 exited
  • 28 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 82.3%
Technology 1.1%
Energy 0.0%
Other 11.7%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 911.53K $448.14M 7.22%
7.22%
New
2 9.23M $418.84M 6.75%
6.75%
New
3 1.00M $348.69M 5.62%
5.62%
New
4 2.58M $290.65M 4.68%
4.68%
New
5 829.00K $242.31M 3.90%
3.90%
New
6 3.17M $165.14M 2.66%
2.66%
New
7 894.35K $158.39M 2.55%
2.55%
New
8 1.50M $154.45M 2.49%
2.49%
New
9 1.56M $151.18M 2.44%
2.44%
New
10 2.49M $143.93M 2.32%
2.32%
New
11 2.65M $139.72M 2.25%
2.25%
New
12 4.72M $130.69M 2.11%
2.11%
New
13 258.20K $130.18M 2.10%
2.10%
New
14 475.61K $129.97M 2.09%
2.09%
New
15 2.25M $126.43M 2.04%
2.04%
New
16 3.68M $100.13M 1.61%
1.61%
New
17 4.01M $99.33M 1.60%
1.60%
New
18 170.05K $82.73M 1.33%
1.33%
New
19 3.16M $79.86M 1.29%
1.29%
New
20 304.23K $78.65M 1.27%
1.27%
New
21 1.12M $76.39M 1.23%
1.23%
New
22 173.89K $75.71M 1.22%
1.22%
New
23 2.28M $73.90M 1.19%
1.19%
New
24 3.51M $72.30M 1.17%
1.17%
New
25 1.03M $71.04M 1.15%
1.15%
New
26 685.73K $63.98M 1.03%
1.03%
New
27 7.25M $60.50M 0.97%
0.97%
New
28 237.25K $57.39M 0.93%
0.93%
New
29 1.90M $52.29M 0.84%
0.84%
New
30 158.44K $51.95M 0.84%
0.84%
New
31 2.38M $51.91M 0.84%
0.84%
New
32 166.89K $50.95M 0.82%
0.82%
New
33 254.28K $50.63M 0.82%
0.82%
New
34 641.49K $50.27M 0.81%
0.81%
New
35 114.44K $50.04M 0.81%
0.81%
New
36 134.33K $48.15M 0.78%
0.78%
New
37 4.53M $47.91M 0.77%
0.77%
New
38 9.80M $45.68M 0.74%
0.74%
New
39 224.10K $45.59M 0.73%
0.73%
New
40 229.34K $44.95M 0.72%
0.72%
New
41 2.14M $44.51M 0.72%
0.72%
New
42 631.49K $44.13M 0.71%
0.71%
New
43 81.54K $43.80M 0.71%
0.71%
New
44 264.36K $42.16M 0.68%
0.68%
New
45 2.13M $41.74M 0.67%
0.67%
New
46 4.88M $41.08M 0.66%
0.66%
New
47 898.40K $40.78M 0.66%
0.66%
New
48 155.64K $38.29M 0.62%
0.62%
New
49 125.50K $35.90M 0.58%
0.58%
New
50 266.23K $34.46M 0.56%
0.56%
New

FAQ

What did Bellevue Group AG buy in 2023-Q3?

In its 2023-Q3 13F filing, Bellevue Group AG reported 154 equity positions worth $6.21B in aggregate; its largest disclosed positions were ARGX ($448.14M), IONS ($418.84M), VRTX ($348.69M).

How large is Bellevue Group AG's portfolio?

Bellevue Group AG reported $6.21B of long equity holdings across 154 positions as of 2023-Q3. Top-10 holdings account for 40.6% of reported value.

What is Bellevue Group AG's investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/bellevue-group-ag/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →